Who owns ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1?
- CUSIP Number: 02043qab3
Tip: Access positions for across all investors
Analyze quarterly positions in Alnylam Pharmaceuticals Inc Note 1.000 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alnylam Pharmaceuticals Inc Note 1.000 9/1 stock
Who bought or sold ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ubs Global Asset Management Americas | 71M | $66M | -5% | Mar 2024 |
|
| Calamos Advisors | 47M | $44M | -16% | Mar 2024 |
|
| Opti Capital Management | 36M | $33M | 100% | Mar 2024 |
|
| Steelhead Partners | 35M | $33B | -36% | Mar 2024 |
|
| Aequim Alternative Investments | 35M | $33M | -14% | Mar 2024 |
|
| Citadel Advisors | 34M | $32M | 176% | Mar 2024 |
|
| Davidson Kempner Capital Management | 30M | $28M | -14% | Mar 2024 |
|
| Lazard Asset Management | 30M | $29M | 100% | Dec 2023 |
|
| Readystate Asset Management | 25M | $24M | -64% | Mar 2024 |
|
| D. E. Shaw & Co | 24M | $23M | 100% | Mar 2024 |
|
| Zazove Associates | 23M | $22M | 0% | Mar 2024 |
|
| Shenkman Capital Management | 16M | $16B | 15% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 13M | $12M | 0% | Mar 2024 |
|
| Capstone Investment Advisors | 13M | $12M | -29% | Mar 2024 |
|
| MacKay Shields | 12M | $11M | 0% | Mar 2024 |
|
| Lombard Odier Asset Management | 11M | $11M | -25% | Mar 2024 |
|
| Wellington Management Company | 11M | $11M | 34% | Dec 2023 |
|
| Morgan Stanley | 10M | $9.4M | -7% | Mar 2024 |
|
| FMR | 8.6M | $8.1M | -42% | Mar 2024 |
|
| Mint Tower Capital Management B.V. | 8.5M | $8.0M | 100% | Mar 2024 |
|
| BlackRock | 7.9M | $7.4M | 13% | Mar 2024 |
|
| Axa | 7.7M | $7.2M | -3% | Mar 2024 |
|
| Moore Capital Management | 6.0M | $5.6M | 100% | Mar 2024 |
|
| Wells Fargo & Company | 5.8M | $5.5M | -23% | Mar 2024 |
|
| Franklin Resources | 5.5M | $5.2M | 100% | Mar 2024 |
|
| Man Group | 5.4M | $5.1M | 0% | Mar 2024 |
|
| New York State Common Retirement Fund | 5.3M | $4.9M | -13% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 5.0M | $4.7M | 100% | Mar 2024 |
|
| SSI Investment Management | 4.9M | $4.8M | 1% | Dec 2023 |
|
| Bank Of Montreal | 4.3M | $4.1M | -54% | Mar 2024 |
|
| RWC Asset Management | 4.2M | $4.0M | 31% | Mar 2024 |
|
| Royal Bank of Canada | 4.0M | $3.8M | 87% | Mar 2024 |
|
| Boothbay Fund Management | 3.3M | $3.1M | 100% | Mar 2024 |
|
| Amundi | 3.2M | $2.9M | 0% | Mar 2024 |
|
| Aristeia Capital | 3.0M | $2.8M | 100% | Mar 2024 |
|
| Citigroup | 2.6M | $2.4M | 102% | Mar 2024 |
|
| Edmond De Rothschild Holding | 1.6M | $1.5M | 0% | Mar 2024 |
|
| Liberty Mutual Group Asset Management | 1.5M | $1.4M | 0% | Mar 2024 |
|
| Credit Suisse | 1.5M | $1.5M | -67% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.2M | $1.1M | 922% | Mar 2024 |
|
| Leucadia National Corporation | 1.1M | $1.0M | 37% | Mar 2024 |
|
| Nicholas Investments Partners | 1.1M | $1.1M | 0% | Dec 2023 |
|
| Aviva | 600k | $564k | -40% | Mar 2024 |
|
| Bank of New York Mellon | 600k | $566k | 0% | Mar 2024 |
|
| Groupama Asset Managment | 600k | $524k | 0% | Mar 2024 |
|
| Russell Investments | 541k | $509k | 1051% | Mar 2024 |
|
| Palisade Capital Management | 489k | $460k | -22% | Mar 2024 |
|
| KBC Group NV | 300k | $283k | 0% | Mar 2024 |
|
| Bank of America Corporation | 157k | $148k | 100% | Mar 2024 |
|
| Sei Investments | 99k | $93k | 0% | Mar 2024 |
|
| Calamos Wealth Management | 93k | $87k | -75% | Mar 2024 |
|
| Nomura Holdings | 68k | $10M | -13% | Mar 2024 |
|
| Virtus Investment Advisers | 47k | $44k | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 22k | $21k | -99% | Mar 2024 |
|
| SG Americas Securities | 18k | $1.7M | -53% | Mar 2024 |
|
| EverSource Wealth Advisors | 3.0k | $3.0k | 0% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 800.00 | $755k | 14% | Mar 2024 |
|
Who sold out of Alnylam Pharmaceuticals Inc Note 1.000 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 86M | $80B |
| Wolverine Asset Management | Dec 2023 | 30M | $30M |
| Nuveen Asset Management | Sep 2023 | 18M | $16M |
| CNH Partners | Dec 2023 | 14M | $13M |
| Jane Street | Dec 2023 | 9.4M | $9.0M |
| Context Capital Management | Dec 2023 | 7.0M | $6.9B |
| Walleye Trading Advisors | Dec 2023 | 2.5M | $2.5M |
| CSS | Dec 2023 | 2.4M | $2.3M |
| First Hawaiian Bank | Dec 2023 | 106k | $104k |
| Verition Fund Management | Sep 2023 | 4.3k | $3.9M |